Automatic Brain Tumor Detection Using K-Means and RFLICM
inherently serious and life threatening. Most of research in developed countries shows that the numbers of people who have brain tumors were died due to the fact of inaccurate detection
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
inherently serious and life threatening. Most of research in developed countries shows that the numbers of people who have brain tumors were died due to the fact of inaccurate detection
intended to briefly emphasize the mediating role and importance of multifunctional nanoparticles in the development of rapid, sensitive and effective diagnostic and therapeutic tools for the deadliest diseases. In this…
aspects of brain function, including fundamental levels of processing such as attention, are being investigated in SCI. The aim of this study is to inform the development of more sensitive
serological positivity to CMV, HHV-6 and EBV were investigated. Virus positivity in brain specimens from a third cohort of AD was also detected. Leukocyte positivity ... increased in those elderly who developed clinical…
reviewed. In addition, several forums and workshops were conductedto develop consensus in relation to developing recommendations for a new Framework. Results and outcomes: A number of barriers were identified…
secreted with insulin by pancreatic B-cells, has binding sites in the brain possibly regulating satiety and gastric emptying. It is elevated in obesity and pre-diabetic insulin resistance (hyperamylinemia ... important…
regulating nitric oxide levels and mediating BDNF secretion when brain cells experience high levels of inflammatory stress, we are developing drugs that selectively target the S1R. By exploiting functionally selective
blood brain barrier, Galantamaine has very poor bioavailability to the brain. Hence, an attempt was made to develop polysorbate 80 coated galantamine nanoparticles to target brain. The nanoparticles were successfully
suggesting that early pharmacological prevention of brain circuit alterations might represent a more promising strategy towards delaying the development of Alzheimer�s disease
Disease (AD) is characterized by abnormal extracellular accumulation of β-Amyloid peptide in the brains of patients. The pathological isoform Aβ1-42 (Aβ42) agregates magnitudes of order faster than Aβ40 ... biomarkers…
levels in brain tissues. The ICV STZ injection showed a significant decline in the brain acetylcholine levels. However, administration of ASF (5, 10 and 20 mg/kg) significantly reversed ... urgent need for the…
current investigation was to study the effect of sleep deprivation (SD) on the development of AD phenotype in a transgenic mouse model with plaques and tangles, the 3xTg mice. Compared ... brains of sleep-deprived mice…
disease (AD) and a better understanding of inflammation mechanisms may potentially help to develop new approaches to treat this disorder. Methods: Confocal microscopy studies were performed to evaluate inflammation…
autopsy studies, some approaches have succeeded in decreasing beta-amyloid in the brain of mild-moderate patients but none has produced clinically significant results in phase III. Most recently, antibodies ... advanced…
cerebral palsy, mental retardation and other sequel which were caused by perinatal brain damage, and promote the development of movement, cognitive, language ... social and other functions. And its mechanism may be…
data that do exist showed the majority of the elderly subjects after age 80 develop an MCI syndrome, and that more than half of them progressed to dementia. Because neuroimaging ... dementia is not always linear. In…
been reported that there is increased inflammation in metabolic syndrome that facilitates the development of hepatosteatosis. Cognitive dysfunction generally refers to deficits in memory and executive function, and many…
Casablanca Neurology Department. These patients underwent standard somatic neurological examination, cognitive function assessment, brain imaging and laboratory tests. Direct sequencing of each exon in PS1 and PS2 genes…
aged brain, characterized by the deterioration of cognitive functions. It affects millions of people and has become a major medical and social problem for developing societies. Current therapeutic options ... agent that…
years before clinical symptoms present. We have developed some Gd-containing contrast agents that bind fibrillar β-amyloid deposits in the brain, and can aid visualization ... deposits in brain, which works at higher…
GLUT1 in brain capillaries. However, an increase of 41.3% of RAGE was found in brain capillaries of 12-month-old APOE4 mice compared to APOE2 without significant changes of LRP1 ... investigations are needed to…
disease (AD) is likely caused by deposition of amyloid beta peptides in plaques in brain tissue. However, this �amyloid beta hypothesis� has been challenged lately by clinical studies.Amyloid beta peptides ... human and…
therapeutic proteins have been used to treat Alzheimer�s, Parkinson�s, stroke and other brain disorders in animal models. The intranasal insulin treatment for Alzheimer�s disease, which the author ... reduce the risk of…
their changes in the human brain occurring during aging or at different stages of AD, phospholipids are an interesting target for development of novel safe and effective treatment strategies against
with CD. Conclusions: Brain metabolic supply is determined by functional integration of CBF, CSF systems and skull biomechanics and two last play roles in dementia developing
For authors and organisers
Find the right journal for your paper and submit your manuscript.